Condition

Heart Decompensation

ClinicalTrials.gov condition label

Clinical trials29
Recruiting2
Common interventions25
Lead sponsors shown15

Clinical trials

29 shown
Social Prescribing to Improve Adherence and Outcomes in Women With Heart FailureNCT06628973 · 2025-10-23
RECRUITING
Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementNCT06814990 · 2024-04-19
RECRUITING
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableNCT06763549 · 2024-11-16
ENROLLING_BY_INVITATION
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart FailureNCT05747820 · 2022-09-28
COMPLETED
RAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure RehospitalizationNCT04703504 · 2022-07-15
TERMINATED
Comparison of PEEP in Acute Decompensated Heart FailureNCT04853563 · 2021-04-20
UNKNOWN
Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure PatientsNCT04698954 · 2020-12-14
COMPLETED
Interest of the Smartphone Application "MonCœur" in the Follow-up of Patients With Heart FailureNCT04198779 · 2020-02-12
TERMINATED
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticNCT03730961 · 2019-01-17
COMPLETED
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver FunctionNCT03515980 · 2018-05-25
COMPLETED
Study of the Sudden Heart Failure Participant Population in the USNCT03566264 · 2017-08-22
WITHDRAWN
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHFNCT02649998 · 2017-01-01
WITHDRAWN
Skeletal Muscles in Acute Heart FailureNCT03102164 · 2016-04-21
UNKNOWN
Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure PatientsNCT02324400 · 2015-01-01
UNKNOWN
Early-start Exercise Training in Subacute Heart FailureNCT02051985 · 2013-10-01
UNKNOWN
Pronostic Value of Endothelial Dysfunction in Heart FailureNCT02859636 · 2012-10-01
TERMINATED
Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart FailureNCT06255418 · 2012-01-01
COMPLETED
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)NCT01064037 · 2010-04-01
TERMINATED
Treating Congestive Heart Failure Using a Device to Remove CholesterolNCT00510601 · 2007-07-01
COMPLETED
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart FailureNCT00475852 · 2007-05-01
COMPLETED
An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart FailureNCT00813202 · 2006-10-01
COMPLETED
Effects of Nesiritide in Pediatric Patients With Heart FailureNCT00166010 · 2004-10-01
WITHDRAWN
Registry for Acute Decompensated Heart Failure Patients Admitted to the ERNCT00364325 · 2004-07-01
COMPLETED
Evaluation of the Effects of Carperitide in Patients With Congestive Heart FailureNCT00259038 · 2004-01-01
COMPLETED
Longitudinal Registry for Advanced Heart Failure PatientsNCT00364416 · 2002-10-01
COMPLETED
Registry for Acute Decompensated Heart Failure PatientsNCT00366639 · 2001-10-01
COMPLETED
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood VesselsNCT00271557 · 1997-01-01
COMPLETED
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at RestNCT00288730 · 1996-10-01
COMPLETED
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart FailureNCT02973620
NO_LONGER_AVAILABLE

Common interventions

NesiritideDRUG5PlaceboDRUG4Acute Decompensated Heart FailureOTHER2BMS-986231DRUG2FurosemideDRUG2Adherence Improving self-Management StrategyBEHAVIORAL1Aerobic exercise trainingOTHER1Any treatment used to treat CHFOTHER1APPLIDEVICE1Blood samplesDIAGNOSTIC_TEST1Cardiac MRIDIAGNOSTIC_TEST1cardiac rehabilitationPROCEDURE1CarperitideDRUG1Cinaciguat (BAY58-2667)DRUG1EchocardiographyDIAGNOSTIC_TEST1Isosorbide DinitrateDRUG1Kaneka LiposorberDEVICE1LevosimendanDRUG1Multiple intervention programOTHER1Non-InterventionalOTHER1Observational studyOTHER1PEEPOTHER1RenaSense Sham ControlDEVICE1RenaSense StimulationDEVICE1Social prescribingBEHAVIORAL1

Trial status mix

COMPLETED14
TERMINATED4
UNKNOWN4
WITHDRAWN3
RECRUITING2
ENROLLING_BY_INVITATION1
NO_LONGER_AVAILABLE1

Phase mix

NA9
PHASE24
PHASE34
PHASE12
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.